Abstract:Mitochondria, which generate ATP through aerobic respiration, also have important noncanonical functions. Mitochondria are dynamic organelles, that engage in fission (division), fusion (joining) and translocation. They also regulate intracellular calcium homeostasis, serve as oxygen-sensors, regulate inflammation, participate in cellular and organellar quality control and regulate the cell cycle. Mitochondrial fission is mediated by the large GTPase, dynamin-related protein 1 (Drp1) which, when activated, translocates to the outer mitochondrial membrane (OMM) where it interacts with binding proteins (Fis1, MFF, MiD49 and MiD51). At a site demarcated by the endoplasmic reticulum, fission proteins create a macromolecular ring that divides the organelle. The functional consequence of fission is contextual. Physiological fission in healthy, nonproliferating cells mediates organellar quality control, eliminating dysfunctional portions of the mitochondria via mitophagy. Pathological fission in somatic cells generates reactive oxygen species and triggers cell death. In dividing cells, Drp1-mediated mitotic fission is critical to cell cycle progression, ensuring that daughter cells receive equitable distribution of mitochondria. Mitochondrial fusion is regulated by the large GTPases mitofusin-1 (Mfn1) and mitofusin-2 (Mfn2), which fuse the OMM, and optic atrophy 1 (OPA-1), which fuses the inner mitochondrial membrane. Mitochondrial fusion mediates complementation, an important mitochondrial quality control mechanism. Fusion also favors oxidative metabolism, intracellular calcium homeostasis and inhibits cell proliferation. Mitochondrial lipids, cardiolipin and phosphatidic acid, also regulate fission and fusion, respectively. Here we review the role of mitochondrial dynamics in health and disease and discuss emerging concepts in the field, such as the role of central versus peripheral fission and the potential role of dynamin 2 (DNM2) as a fission mediator. In hyperproliferative diseases, such as pulmonary arterial hypertension and cancer, Drp1 and its binding partners are upregulated and activated, positing mitochondrial fission as an emerging therapeutic target.

Role of GTPase-Dependent Mitochondrial Dynamins in Heart Diseases

Effects of Mitochondrial Dynamics in the Pathophysiology of Obesity.

Molecular regulation of mitochondrial dynamics in cardiac disease

Mitochondria-associated membrane-modulated Ca<SUP>2+</SUP> transfer: A potential treatment target in cardiac ischemia reperfusion injury and heart failure

Deregulation of Mitochondrial Fusion and Fission in Neurodegenerative Diseases

The role of mitochondrial dynamics in disease

Mitochondrial dynamics and cell death in heart failure

Current Understanding of the Pivotal Role of Mitochondrial Dynamics in Cardiovascular Diseases and Senescence

Dysregulation of Mfn2 and Drp-1 proteins in heart failure

The Role of Mitochondrial Fusion and Fission in the Process of Cardiac Oxidative Stress.

Mitochondrial Dynamics and Mitophagy in Cardiometabolic Disease

Novel insights into the involvement of mitochondrial fission/fusion in heart failure: From molecular mechanisms to targeted therapies

Mitochondrial dynamics and inter-mitochondrial communication in the heart

[Role of mitochondrial dynamics in diabetic cardiomyopathy and regulatory mechanisms]

Drp1-dependent mitochondrial fission in cardiovascular disease

Mitochondrial Dysfunction in Heart Failure and Its Therapeutic Implications

The role of mitochondrial dynamics in cardiovascular diseases

The Role of Mitochondrial Dynamics and Mitotic Fission in Regulating the Cell Cycle in Cancer and Pulmonary Arterial Hypertension: Implications for Dynamin-Related Protein 1 and Mitofusin2 in Hyperproliferative Diseases

Mitochondrial autophagy: molecular mechanisms and implications for cardiovascular disease

Role of the Mitochondrial Protein Import Machinery and Protein Processing in Heart Disease

Mitochondrial Function and Dysfunction in Dilated Cardiomyopathy